◈ Nootpedia
Extended Research →
Verdict, decision matrix, deep dives, sourcing notes & full sources

Hydrochlorothiazide (HCTZ)

Cheap, generic, evidence-rich first-line thiazide diuretic for hypertension. | Compound

Aliases (7)
HCTZ · HCT · Microzide · Esidrix · HydroDIURIL · Oretic · thiazide
TYPICAL DOSE
12.5-25 mg PO once daily; rarely 50 mg
ROUTE
—
CYCLE
—
STORAGE
—
✎
Did you know? You can suggest edits to improve this compound's information.
Submitted via email — no account required.
Suggest an edit
▸ Overview TL;DR

Cheap, generic, evidence-rich first-line thiazide diuretic for hypertension. Bodybuilders use it pre-show for water-cut "dryness" — a use case associated with on-stage collapses, ICU admissions for severe hypokalemia, and at least several documented competition deaths. Not relevant for Dylan: no HTN, no cutting context, no upside, real downside.

▸ Mechanism of action

HCTZ inhibits the apical Na+/Cl- cotransporter (NCC, encoded by SLC12A3) on distal convoluted tubule cells. Net effect: increased urinary excretion of Na, Cl, and obligate water. Secondary effects:

  • ↑ K+ secretion at downstream principal cells (low Na delivery + aldosterone effect) → hypokalemia
  • ↑ Mg2+ excretion → hypomagnesemia
  • ↑ Ca2+ reabsorption (paradoxical — useful in stone prevention)
  • ↑ uric acid retention → hyperuricemia / gout flare
  • Mild ↑ insulin resistance and ↑ glucose
  • Mild ↑ LDL/triglycerides
  • Long-term BP-lowering exceeds what natriuresis alone explains — believed to involve vasodilatory effects
▸ Pharmacokinetics Approximate
t½: 40-60h
100% 50% 0% 0 3d 5d 8d 10d t½ Peak

Approximate decay curve drawn from the half-life mention(s) in the source notes. Real PK data not yet ingested per compound.

▸ What to expect Generic
  1. 1
    Week 1
    Tolerability and dose-response.
  2. 2
    Week 2-4
    Early effect window.
  3. 3
    Week 4-8
    Peak benefit assessment.
  4. 4
    Week 8+
    Cycle decision point.
▸ Side effects + safety
  • Common (>10%): Hypokalemia (especially at 50 mg+), hyponatremia (especially elderly), hypomagnesemia, hyperuricemia, mild hyperglycemia, mild dyslipidemia, photosensitivity
  • Less common (1-10%): Sexual dysfunction, gout flare, dizziness, dehydration
  • Rare-serious (<1%):
    • Severe hypokalemia → fatal arrhythmia. This is the bodybuilding-cutting kill mechanism — torsades de pointes, V-fib on stage or in dressing room.
    • Hyponatremic encephalopathy (especially with low-Na intake)
    • Acute angle-closure glaucoma (idiosyncratic — small risk window first weeks)
    • Pancreatitis (rare)
    • Stevens-Johnson syndrome / TEN (very rare)
    • Skin cancer (non-melanoma) — Danish registry data 2017-2018 showed ~7× increased risk of squamous cell carcinoma with cumulative high HCTZ exposure due to photosensitization. FDA / EMA added label warnings.
  • Specific watch periods: First 2 weeks for hyponatremia/hypokalemia; ongoing photoprotection; periodic SCC skin checks for chronic users
▸Interactions7 compounds
  • Medical:Synergistic
    ACEi/ARB combos (lisinopril/HCTZ, valsartan/HCTZ, telmisartan/HCTZ) — synergistic BP lowering with K+ neutralization
  • Medical:Synergistic
    Loop diuretic in resistant edema (sequential nephron blockade)
  • LithiumAvoid
    (HCTZ ↑ lithium reabsorption → toxicity)
  • Other K+-wasting drugsAvoid
    (loop diuretics, corticosteroids, amphotericin) without supplementation
  • Bodybuilding:Avoid
    Other diuretics (furosemide stacked with thiazide for "synergy") — has killed competitors
  • Beta-2 agonistsAvoid
    (clenbuterol stack — additive K+ loss)
  • NSAIDs chronicallyAvoid
    (blunts BP effect, raises kidney injury risk)
▸References5 sources

ALLHAT Officers (2002) — Major outcomes in high-risk hypertensive patients randomized to ACEI vs CCB vs diuretic. JAMA

2002

PMID 12479763, landmark HTN trial

pubmed.ncbi.nlm.nih.govView →

Pedersen SA, et al. (2018) — Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. J Am Acad Dermatol

2018

PMID 29217346, the SCC signal

pubmed.ncbi.nlm.nih.govView →

Roush GC, et al. (2012) — Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension

2012

PMID 22232136, head-to-head with chlorthalidone

pubmed.ncbi.nlm.nih.govView →

Al-Falahi Z, et al. (2022) — Sudden cardiac death in athletes: where are we now? Heart

2022

PMID 35105657, athlete sudden death context (electrolyte/diuretic share)

pubmed.ncbi.nlm.nih.govView →

Sica DA (2004) — Diuretic-related side effects: development and treatment. J Clin Hypertens

2004

PMID 15539962, classic safety review

pubmed.ncbi.nlm.nih.govView →
Was this helpful?
Your feedback shapes what we research deeper.
Continue: Extended Research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Hydrochlorothiazide (HCTZ)
Eplerenone
NOT-RELEVANT
Selective mineralocorticoid receptor antagonist (selective MRA / "second-gen aldosterone blocker")
HIGH
Telmisartan
NOT-RELEVANT
Angiotensin II receptor blocker (ARB) — selective AT1 antagonist with partial PPARγ agonism
HIGH
Clonidine
WATCH-LIST
Centrally-acting α2-adrenergic receptor agonist (non-selective α2A/α2B/α2C); imidazoline I1 agonist
HIGH
Novolin R (regular human insulin)
SKIP-PERMANENT
Short-acting recombinant human insulin (hexameric)
HIGH
Semaglutide
SKIP-FOR-NOW
GLP-1 receptor agonist (single-target incretin mimetic). Once-weekly subcutaneous (Ozempic for T2D, Wegovy for obesity) or once-daily oral (Rybelsus for T2D).
HIGH